Literature DB >> 3415362

Participation of antigens related to the psoriasis associated antigen, pso p27, in immune complex formation in patients with ankylosing spondylitis.

E Rødahl1, K Asbakk, O J Iversen.   

Abstract

Analysis of five serum samples and three synovial fluids from patients with ankylosing spondylitis (AS) and five serum samples from healthy blood donors for the presence of antibodies cross reacting with the Fc part of rabbit IgG (rheumatoid factors (RFs] using an isotype specific, enzyme linked immunosorbent assay (ELISA) showed only insignificant amounts of free RFs, while IgG RFs were observed in alkaline dissociated circulating immune complexes (CICs). Only insignificant amounts of free antibodies reacting with the psoriasis associated antigen pso p27 could be detected in the samples, while extensive amounts of IgG antibodies and moderate amounts of IgM antibodies reacting with pso p27 were detected in alkaline dissociated CICs from the patients. Pso p27 has been reported to share a common determinant with the Fc part of human IgG. Removal of the RF activity from the CICs of patients with AS by absorption with IgG resulted in a decrease of the anti-pso p27 activity. Monoclonal anti-pso p27 antibodies in a sandwich ELISA were used to detect antigens cross reacting with pso p27. A positive reaction was observed in all serum CICs and in one of the synovial fluid CICs. The data indicate that antigens related to pso p27 participate in CIC formation in AS and may also be responsible for the elicitation of rheumatoid factors in patients with AS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415362      PMCID: PMC1006712          DOI: 10.1136/ard.47.8.628

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Immune complex disease in chronic viral infections.

Authors:  M B Oldstone; F J Dixon
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

2.  Antiglobulins in ankylosing spondylitis.

Authors:  R M Arana; M T de la Vega; A Porrini; O Garcia Morteo
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

3.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

4.  Isolation of virus and antibody containing immune complexes from mink with Aleutian disease by affinity chromatography of equine complement clq.

Authors:  D Burger; N Sriranganathan; T L McDonald; J R Gorham
Journal:  Am J Vet Res       Date:  1983-01       Impact factor: 1.156

5.  Rheumatoid factors in psoriatic scale, serum and circulating immune complexes detected by an isotype-specific ELISA.

Authors:  K Asbakk; O J Iversen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1987-08

6.  The distribution of clinical findings in Bechterew's syndrome (ankylosing spondylitis) suggests distinct genetic subgroups.

Authors:  P Møller; O Vinje; E Kåss; K Berg
Journal:  Clin Genet       Date:  1982-10       Impact factor: 4.438

7.  Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption.

Authors:  H W Snyder; F R Jones; N K Day; W D Hardy
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

8.  Chronic arthritis in goats caused by a retrovirus.

Authors:  T B Crawford; D S Adams; W P Cheevers; L C Cork
Journal:  Science       Date:  1980-02-29       Impact factor: 47.728

9.  The HLA system and the arthropathies associated with psoriasis.

Authors:  C J Eastmond; J C Woodrow
Journal:  Ann Rheum Dis       Date:  1977-04       Impact factor: 19.103

10.  A spontaneous rheumatoid arthritis-like disease in MRL/l mice.

Authors:  L Hang; A N Theofilopoulos; F J Dixon
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.